Curriculum

Breaking Down Metabolic Liver Disease: A Primary Care Approach To MASLD And MASH

This curriculum, consisting of a 30-minute podcast and a 60-minute PrimaryCareNOW session, reviews disease mechanisms, risk factors, and comorbidities, covers noninvasive tools for screening and risk stratification, and outlines guideline-based strategies for managing MASLD and MASH with a focus on risk factor reduction and cardiometabolic health.

Loading... Begin

CME Information

1.50 AMA PRA Category 1 Credits™, 1.50 ABIM MOC or 1.42 AANP, 0.54 AANP Pharm

Available for credit until 7/23/2026

Topics

Faculty

Learning Objectives

  • Discuss the key pathophysiologic mechanisms, metabolic comorbidities, risk factors, and health consequences of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH)
  • Use noninvasive tools to screen, risk stratify, and guide treatment in patients with MASLD and MASH
  • Apply current guideline-directed management of MASLD and MASH, with a focus on risk factor reduction and management of comorbid cardiometabolic disease

Courses

1.50 CME/CE CREDITS

2 Courses

Downloadable Resources

 

 

Faculty Information

Vani Potluri, MD

Assistant Professor of Medicine, Section of General Internal Medicine, Baylor College of Medicine, Houston, Texas

Read More
Maddie J. Kubiliun, MD, MPH

Assistant Professor of Medicine, Division of Digestive and Liver Diseases, Associate Program Director | Internal Medicine Residency Program, University of Texas Southwestern Medical Center, Dallas, TX

Read More
Ivory Allison

National Senior Director of Community Impact, American Liver Foundation

Read More

Supported By

This activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Education Partners

Pri-Med Institute

American Liver Foundation